Kohli, M.; Tan, W.; Vire, B.; Liaud, P.; Blairvacq, M.; Berthier, F.; Rouison, D.; Garnier, G.; Payen, L.; Cousin, T.;
et al. Prognostic Value of Plasma hPG80 (Circulating Progastrin) in Metastatic Renal Cell Carcinoma. Cancers 2021, 13, 375.
https://doi.org/10.3390/cancers13030375
AMA Style
Kohli M, Tan W, Vire B, Liaud P, Blairvacq M, Berthier F, Rouison D, Garnier G, Payen L, Cousin T,
et al. Prognostic Value of Plasma hPG80 (Circulating Progastrin) in Metastatic Renal Cell Carcinoma. Cancers. 2021; 13(3):375.
https://doi.org/10.3390/cancers13030375
Chicago/Turabian Style
Kohli, Manish, Winston Tan, Bérengère Vire, Pierre Liaud, Mélina Blairvacq, Frederic Berthier, Daniel Rouison, George Garnier, Léa Payen, Thierry Cousin,
and et al. 2021. "Prognostic Value of Plasma hPG80 (Circulating Progastrin) in Metastatic Renal Cell Carcinoma" Cancers 13, no. 3: 375.
https://doi.org/10.3390/cancers13030375
APA Style
Kohli, M., Tan, W., Vire, B., Liaud, P., Blairvacq, M., Berthier, F., Rouison, D., Garnier, G., Payen, L., Cousin, T., Joubert, D., & Prieur, A.
(2021). Prognostic Value of Plasma hPG80 (Circulating Progastrin) in Metastatic Renal Cell Carcinoma. Cancers, 13(3), 375.
https://doi.org/10.3390/cancers13030375